Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1959 Jul;35(7):433–449.

Drug-Induced Hemolytic Anemias and Congenital Galactosemia*

Paul A Marks, Ruth T Gross
PMCID: PMC1806188  PMID: 13662732

Full text

PDF
433

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALVING A. S., CARSON P. E., FLANAGAN C. L., ICKES C. E. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science. 1956 Sep 14;124(3220):484–485. doi: 10.1126/science.124.3220.484-a. [DOI] [PubMed] [Google Scholar]
  2. ANDERSON E. P., ISSELBACHER K. J., KALCKAR H. M. Defect in uptake of galactose-1-phosphate into liver nucleotides in congenital galactosemia. Science. 1957 Jan 18;125(3238):113–114. doi: 10.1126/science.125.3238.113. [DOI] [PubMed] [Google Scholar]
  3. BEUTLER E., DERN R. J., ALVING A. S. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med. 1954 Aug;44(2):177–184. [PubMed] [Google Scholar]
  4. BEUTLER E., DERN R. J., ALVING A. S. The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med. 1954 Sep;44(3):439–442. [PubMed] [Google Scholar]
  5. BEUTLER E., DERN R. J., FLANAGAN C. L., ALVING A. S. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med. 1955 Feb;45(2):286–295. [PubMed] [Google Scholar]
  6. BEUTLER E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957 Jan;49(1):84–95. [PubMed] [Google Scholar]
  7. BRIN M., YONEMOTO R. H. Stimulation of the glucose oxidative pathway in human erythrocytes by methylene blue. J Biol Chem. 1958 Jan;230(1):307–317. [PubMed] [Google Scholar]
  8. DERN R. J., BEUTLER E., ALVING A. S. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med. 1954 Aug;44(2):171–176. [PubMed] [Google Scholar]
  9. FLANAGAN C. L., SCHRIER S. L., CARSON P. E., ALVING A. S. The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity. J Lab Clin Med. 1958 Apr;51(4):600–608. [PubMed] [Google Scholar]
  10. GROSS R. T., HURWITZ R. E., MARKS P. A. An hereditary enzymatic defect in erythrocyte metabolism: glucose-6-phosphage dehydrogenase deficiency. J Clin Invest. 1958 Aug;37(8):1176–1184. doi: 10.1172/JCI103707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GROSS R. T., MARKS P. A. An hereditary enzymatic defect in red blood cells; its relation to certain drug-induced hemolytic anemias. Ann N Y Acad Sci. 1958 Oct 13;75(1):106–109. doi: 10.1111/j.1749-6632.1958.tb36854.x. [DOI] [PubMed] [Google Scholar]
  12. HOCKWALD R. S., ARNOLD J., CLAYMAN C. B., ALVING A. S. Toxicity of primaquine in Negroes. J Am Med Assoc. 1952 Aug 23;149(17):1568–1570. doi: 10.1001/jama.1952.72930340027010c. [DOI] [PubMed] [Google Scholar]
  13. HOLZEL A., KOMROWER G. M. A study of the genetics of galactosaemia. Arch Dis Child. 1955 Apr;30(150):155–159. doi: 10.1136/adc.30.150.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HORECKER B. L., HIATT H. H. Pathways of carbohydrate metabolism in normal and neoplastic cells. N Engl J Med. 1958 Jan 23;258(4):177–contd. doi: 10.1056/NEJM195801232580406. [DOI] [PubMed] [Google Scholar]
  15. HSIA D. Y., HUANG I., DRISCOLL S. G. The heterozygous carrier in galactosaemia. Nature. 1958 Nov 15;182(4646):1389–1390. doi: 10.1038/1821389a0. [DOI] [PubMed] [Google Scholar]
  16. ISSELBACHER K. J. A mammalian uridinediphosphate galactose pyrophosphorylase. J Biol Chem. 1958 May;232(1):429–444. [PubMed] [Google Scholar]
  17. ISSELBACHER K. J., ANDERSON E. P., KURAHASHI K., KALCKAR H. M. Congenital galactosemia, a single enzymatic block in galactose metabolism. Science. 1956 Apr 13;123(3198):635–636. doi: 10.1126/science.123.3198.635. [DOI] [PubMed] [Google Scholar]
  18. KALCKAR H. M., MAXWELL E. S. Biosynthesis and metabolic function of uridine diphosphoglucose in mammalian organisms and its relevance to certain inborn errors. Physiol Rev. 1958 Jan;38(1):77–90. doi: 10.1152/physrev.1958.38.1.77. [DOI] [PubMed] [Google Scholar]
  19. KIMBRO E. L., Jr, SACHS M. V., TORBERT J. V. Mechanism of the hemolytic anemia induced by nitrofurantoin (furadantin); further observations on the incidence and significance of primaquine-sensitive red cells. Bull Johns Hopkins Hosp. 1957 Nov;101(5):245–257. [PubMed] [Google Scholar]
  20. KURAHASHI K., WAHBA A. J. Interference with growth of certain Escherichia coli mutants by galactose. Biochim Biophys Acta. 1958 Nov;30(2):298–302. doi: 10.1016/0006-3002(58)90054-4. [DOI] [PubMed] [Google Scholar]
  21. MARKS P. A. A newer pathway of carbohydrate metabolism; the pentose phosphate pathway. Diabetes. 1956 Jul-Aug;5(4):276–283. doi: 10.2337/diab.5.4.276. [DOI] [PubMed] [Google Scholar]
  22. MARKS P. A., JOHNSON A. B. Relationship between the age of human erythrocytes and their osmotic resistance: a basis for separating young and old erythrocytes. J Clin Invest. 1958 Nov;37(11):1542–1548. doi: 10.1172/JCI103746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MARKS P. A. Red cell glucose-6-phosphate and 6-phosphogluconic dehydrogenases and nucleoside phosphorylase. Science. 1958 Jun 6;127(3310):1338–1339. doi: 10.1126/science.127.3310.1338. [DOI] [PubMed] [Google Scholar]
  24. SCHRIER S. L., KELLERMEYER R. W., ALVING A. S. Coenzyme studies in primaquine-sensitive erythrocytes. Proc Soc Exp Biol Med. 1958 Nov;99(2):354–356. doi: 10.3181/00379727-99-24348. [DOI] [PubMed] [Google Scholar]
  25. SCHRIER S. L., KELLERMEYER R. W., CARSON P. E., ICKES C. E., ALVING A. S. The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. J Lab Clin Med. 1958 Jul;52(1):109–117. [PubMed] [Google Scholar]
  26. SCHWARZ V., GOLBERG L., KOMROWER G. M., HOLZEL A. Some disturbances of erythrocyte metabolism in galactosaemia. Biochem J. 1956 Jan;62(1):34–40. doi: 10.1042/bj0620034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. SZEINBERG A., ASHER Y., SHEBA C. Studies on glutathione stability in erythrocytes of cases with past history of favism or sulfa-drug-induced hemolysis. Blood. 1958 Apr;13(4):348–358. [PubMed] [Google Scholar]
  28. SZEINBERG A., SHEBA C. Hemolytic trait in oriental Jews connected with an hereditary enzymatic abnormality of erythrocytes. Isr Med J. 1958 Jul-Aug;17(7-8):158–168. [PubMed] [Google Scholar]
  29. TOWNSEND E. H., Jr, MASON H. H., STRONG P. S. Galactosemia and its relation to Laennec's cirrhosis; review of the literature and presentation of six additional cases. Pediatrics. 1951 Jun;7(6):760–773. [PubMed] [Google Scholar]
  30. ZINKHAM W. H., LENHARD R. E., Jr, CHILDS B. A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism. Bull Johns Hopkins Hosp. 1958 Apr;102(4):169–175. [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES